IsoPlexis Corporation Common Stock
ISO was delisted on the 20th of March, 2023.
22 hedge funds and large institutions have $31.8M invested in IsoPlexis Corporation Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 8 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
24% less funds holding
Funds holding: 29 → 22 (-7)
25% less capital invested
Capital invested by funds: $42.3M → $31.8M (-$10.5M)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$470K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$284K |
| 3 |
YU
Yale University
New Haven,
Connecticut
|
+$265K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$134K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$25.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.36M |
| 2 |
SCM
Sio Capital Management
New York
|
-$879K |
| 3 |
RI
RTW Investments
New York
|
-$788K |
| 4 |
ABG
Ally Bridge Group
New York
|
-$315K |
| 5 |
Morgan Stanley
New York
|
-$53.2K |
ISO Hedge Fund Activity: Q3 2022 in Review
22 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in IsoPlexis Corporation Common Stock (ISO) for Q3 2022, worth a combined $31.8M — down 25% from $42.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ISO and 2 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $470K. The largest seller was Millennium Management, cutting an estimated $1.36M.
- 22 institutional investors held IsoPlexis Corporation Common Stock (ISO) as of Q3 2022, down from 29 in Q2 2022.
- Funds reported $31.8M of IsoPlexis Corporation Common Stock stock for Q3 2022, down 25% quarter-over-quarter.
- 2 funds opened new IsoPlexis Corporation Common Stock positions in Q3 2022 and 8 closed out, a net change of -6 holders.
- The largest IsoPlexis Corporation Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $470K added.
- The largest IsoPlexis Corporation Common Stock seller in Q3 2022 was Millennium Management, an estimated $1.36M sold.
Based on aggregated 13F filings for Q3 2022.